1187 related articles for article (PubMed ID: 10479350)
1. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
[TBL] [Abstract][Full Text] [Related]
2. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
4. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
5. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ
Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
[TBL] [Abstract][Full Text] [Related]
6. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
[TBL] [Abstract][Full Text] [Related]
7. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
[TBL] [Abstract][Full Text] [Related]
10. Interactions of griseofulvin with cyclodextrins in solid binary systems.
Veiga MD; Díaz PJ; Ahsan F
J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
[TBL] [Abstract][Full Text] [Related]
11. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat.
Rajendrakumar K; Madhusudan S; Pralhad T
Eur J Pharm Biopharm; 2005 May; 60(1):39-46. PubMed ID: 15848054
[TBL] [Abstract][Full Text] [Related]
13. Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.
Orienti I; Cerchiara T; Zecchi V; Arias Blanco MJ; Gines JM; Moyano JR; Rabasco Alvarez AM
Int J Pharm; 1999 Nov; 190(2):139-53. PubMed ID: 10547454
[TBL] [Abstract][Full Text] [Related]
14. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
Williams RO; Mahaguna V; Sriwongjanya M
Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
[TBL] [Abstract][Full Text] [Related]
16. Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes.
Ai F; Ma Y; Wang J; Li Y
Iran J Pharm Res; 2014; 13(4):1115-23. PubMed ID: 25587299
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
18. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin-cyclodextrin complexation: solubility and stability.
Ansari MT; Iqbal I; Sunderland VB
Arch Pharm Res; 2009 Jan; 32(1):155-65. PubMed ID: 19183889
[TBL] [Abstract][Full Text] [Related]
20. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]